| abstract |
A composition for use in the treatment of an inflammatory condition comprising: an isolated or recombinant soluble WSX-1 / IL-27 complex, wherein the inflammatory condition is selected from: an immune disorder, an infection, cancer, an allergy , arthritis, asthma, inflammatory enteropathy, Crohn's disease, uveitis, psoriasis, lupus, multiple sclerosis, a chronic infectious disease, tuberculosis, ankylosing spondylitis, transplant rejection, sarcoidosis and hepatitis. |